GO:0008656 cysteine-type endopeptidase activator activity involved in apoptotic process: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0008656 describes a molecular function: binding to and increasing the rate of proteolysis catalyzed by a cysteine-type endopeptidase (caspase) during apoptosis.
• This activity is central to apoptotic signaling because it controls the activation of executioner caspases that dismantle the cell.
• Dysregulation of caspase activation is implicated in cancer, neurodegeneration, and steroid-induced osteonecrosis of the femoral head.
• Key genes associated with this function include CASP8, CASP9, APAF1, CYCS, TNFRSF10B, and BIRC family members, as identified in transcriptomic and network pharmacology studies.
• Bioinformatics and experimental approaches such as network pharmacology, RNA-seq, and CRISPR knockout models are used to study this activity.
• EDITGENE provides CRISPR knockout, point mutation, knock-in, overexpression, and library screening services to dissect caspase activator function in disease models.
Description
GO:0008656, cysteine-type endopeptidase activator activity involved in apoptotic process, is a molecular function term that captures the ability of a protein to bind and accelerate the proteolytic activity of a cysteine-type endopeptidase (caspase) during programmed cell death. This activity is essential for the initiation and execution of apoptosis, a process that removes damaged or unwanted cells and is frequently altered in human diseases. Understanding which proteins carry this activity and how they are regulated is critical for researchers studying cancer, neurodegeneration, and inflammatory conditions. The term is often studied through transcriptomic profiling, network pharmacology, and functional assays that measure caspase activation and apoptosis. In this article, we integrate authoritative GO annotations with real PubMed literature to provide a research-grade overview of GO:0008656, its associated genes, and the experimental models used to investigate it.
cysteine-type endopeptidase activator activity involved in apoptotic process At A Glance
| GO ID | GO:0008656 |
|---|---|
| GO term | cysteine-type endopeptidase activator activity involved in apoptotic process |
| Ontology | molecular_function |
| Synonym | caspase activator activity |
| Definition | Binds to and increases the rate of proteolysis catalyzed by a cysteine-type endopeptidase involved in the apoptotic process. |
| Major function | Positive regulation of caspase protease activity during apoptosis. |
| Related processes | Apoptotic process, programmed cell death, caspase activation. |
| Representative genes | CASP8, CASP9, APAF1, CYCS, TNFRSF10B, BIRC family members. |
| Research methods | Network pharmacology, RNA-seq, bioinformatics, CRISPR knockout, apoptosis assays. |
What Is GO:0008656?
According to the Gene Ontology, GO:0008656 is defined as the molecular function of binding to and increasing the rate of proteolysis catalyzed by a cysteine-type endopeptidase involved in the apoptotic process. In simpler terms, it is the activity of a protein that helps a caspase enzyme become more active, thereby promoting apoptosis. This function is distinct from the protease activity itself; it is a regulatory activity that enhances caspase-mediated cleavage events during cell death.
Why Is cysteine-type endopeptidase activator activity involved in apoptotic process Important in Cell Biology?
GO:0008656 is important because caspase activation is a point of no return in apoptosis, and its dysregulation contributes to diseases such as cancer, where cells evade death, and neurodegeneration, where excessive apoptosis occurs. Identifying proteins with this activity and understanding their regulation can reveal therapeutic targets and biomarkers. Moreover, many bioinformatics studies of disease datasets highlight caspase-related genes as key hubs, underscoring the broad relevance of this molecular function.
• Controls the initiation and execution of apoptosis by activating caspases.
• Dysregulation is linked to cancer, including gastric cancer and glioblastoma.
• Implicated in steroid-induced osteonecrosis of the femoral head through pyroptosis-related mechanisms.
• Associated with retinoblastoma and chronic myelogenous leukemia in bioinformatics analyses.
• Key genes such as CASP8 and CASP9 are frequently identified as hub genes in disease networks.
• Targeted by natural compounds and drugs, as shown in network pharmacology studies.
• Provides a functional readout for CRISPR screens aimed at identifying apoptotic regulators.
• Enables development of experimental models for apoptosis-related diseases.
What Happens During cysteine-type endopeptidase activator activity involved in apoptotic process?
Initiation of Apoptotic Signaling
In simple terms: The process starts when a death signal tells the cell to begin self-destruction.
Apoptosis can be triggered by extrinsic signals through death receptors such as TNFRSF10B or by intrinsic signals that cause mitochondrial outer membrane permeabilization. These events lead to the recruitment of adaptor proteins and the formation of platforms that facilitate caspase activation.
Activation of Initiator Caspases
In simple terms: Specialized caspase enzymes are switched on to start the demolition.
Initiator caspases such as CASP8 and CASP9 are activated through dimerization or cleavage, a step that can be promoted by activator proteins. The activator activity described by GO:0008656 increases the rate of this proteolytic activation.
Amplification via Executioner Caspases
In simple terms: The signal is amplified as more caspases are activated, leading to cell dismantling.
Once initiator caspases are active, they cleave and activate executioner caspases such as CASP3 and CASP7, which then cleave hundreds of cellular substrates. Activator proteins can further enhance this cascade, ensuring efficient apoptosis.
Regulation by Inhibitors and Modulators
In simple terms: Brakes and accelerators control whether the cell dies.
Inhibitor of apoptosis (IAP) proteins such as BIRC family members can block caspase activity, while activator proteins promote it. The balance between these regulators determines cell fate.
Key Genes Involved in GO:0008656 cysteine-type endopeptidase activator activity involved in apoptotic process
The following genes and proteins are associated with cysteine-type endopeptidase activator activity involved in apoptotic process, as reported in the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CASP8 | Initiator caspase activated by death receptors | Key node in extrinsic apoptosis; identified in network pharmacology studies |
| CASP9 | Initiator caspase activated by cytochrome c | Central to intrinsic apoptosis; hub gene in glioblastoma analyses |
| CASP3 | Executioner caspase | Effector of apoptosis; downstream of activator activity |
| CASP7 | Executioner caspase | Amplifies apoptotic signaling |
| APAF1 | Apoptosome component that activates CASP9 | Essential for intrinsic caspase activation |
| CYCS | Cytochrome c released from mitochondria | Triggers apoptosome formation |
| TNFRSF10B | Death receptor for TRAIL | Extrinsic apoptosis initiator |
| FADD | Adaptor protein for death receptors | Recruits CASP8 to death-inducing signaling complex |
| BIRC2 | Inhibitor of apoptosis protein | Negatively regulates caspase activation |
| BIRC3 | Inhibitor of apoptosis protein | Modulates caspase activity |
| XIAP | Inhibitor of apoptosis protein | Binds and inhibits caspases |
| BID | BH3-only protein linking extrinsic and intrinsic pathways | Promotes cytochrome c release |
| BAX | Pro-apoptotic BCL2 family member | Induces mitochondrial permeabilization |
| BAK1 | Pro-apoptotic BCL2 family member | Induces mitochondrial permeabilization |
| BCL2 | Anti-apoptotic BCL2 family member | Inhibits apoptosis |
| TP53 | Tumor suppressor that induces apoptosis | Upstream regulator of caspase activation |
| NFKB1 | Transcription factor regulating apoptosis genes | Modulates caspase expression |
| MAPK1 | Kinase involved in apoptotic signaling | Identified in network pharmacology |
How Is cysteine-type endopeptidase activator activity involved in apoptotic process Regulated?
The activity of cysteine-type endopeptidase activators is tightly regulated by multiple mechanisms. Inhibitor of apoptosis (IAP) proteins such as BIRC2, BIRC3, and XIAP can bind and inhibit caspases, while pro-apoptotic proteins like BID, BAX, and BAK1 promote caspase activation by facilitating cytochrome c release. Transcriptional regulation by TP53 and NFKB1 also influences the expression of caspase-related genes. Additionally, post-translational modifications and protein-protein interactions within the apoptosome or death-inducing signaling complex modulate the efficiency of caspase activation.
cysteine-type endopeptidase activator activity involved in apoptotic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CASP8 | Gastric cancer, apoptosis evasion | CRISPR knockout in gastric cancer cell lines |
| CASP9 | Glioblastoma, DNA methylation regulation | Knockout or overexpression in glioblastoma cells |
| BIRC2 | Cancer, inhibitor of apoptosis | Point mutation to disrupt caspase binding |
| PYCARD | Steroid-induced osteonecrosis | Knockout in osteoblast models |
| TNFRSF10B | Retinoblastoma, apoptosis signaling | Knock-in of tagged receptor for imaging |
Cancer
Evasion of apoptosis is a hallmark of cancer, and altered expression of caspase activators or inhibitors contributes to tumorigenesis. In gastric cancer, network pharmacology studies have identified caspase-related pathways as targets of natural compounds. In glioblastoma, bioinformatic analyses highlight CASP9 and other apoptosis-related genes as differentially expressed and regulated by DNA methylation. Similarly, in retinoblastoma and imatinib-resistant chronic myelogenous leukemia, caspase pathway genes are among key biomarkers.
Steroid-Induced Osteonecrosis of the Femoral Head
Pyroptosis-related genes, which overlap with apoptotic caspase activation, have been proposed as diagnostic biomarkers in steroid-induced osteonecrosis of the femoral head. This suggests that dysregulated caspase activator activity may contribute to bone tissue damage in this condition.
Neurodegeneration
Excessive apoptosis mediated by caspase activation is implicated in neurodegenerative disorders, although specific studies in the provided citations focus on other diseases. The general mechanism of caspase-dependent cell death is conserved and relevant to neuronal loss.
From cysteine-type endopeptidase activator activity involved in apoptotic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a candidate gene reduce caspase activation? | CRISPR knockout cell line |
| Does a specific mutation in a caspase activator alter its function? | Point mutation knock-in |
| Can a tagged version of the activator be used for imaging? | Knock-in of fluorescent tag |
| Does overexpression of the activator enhance apoptosis? | Overexpression cell line |
| Which genes regulate caspase activation in a disease context? | CRISPR library screening |
| What are the transcriptomic changes upon activator modulation? | RNA-seq and bioinformatics |
How to Study the cysteine-type endopeptidase activator activity involved in apoptotic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Network pharmacology | Compound-target-pathway interactions | Predicting mechanisms of natural compounds |
| RNA-seq | Global gene expression changes | Identifying differentially expressed genes |
| Bioinformatics (WGCNA, PPI) | Hub genes and modules | Discovering key regulators in disease datasets |
| Caspase activity assay | Enzymatic activity of caspases | Validating apoptosis induction |
| Annexin V flow cytometry | Phosphatidylserine externalization | Quantifying apoptotic cells |
| TUNEL assay | DNA fragmentation | Detecting apoptosis in tissues |
| CRISPR knockout | Loss-of-function effects | Testing gene necessity in apoptosis |
| CRISPR library screening | Pooled gene function | Identifying novel apoptotic regulators |
Network Pharmacology and Bioinformatics
Network pharmacology integrates compound-target-pathway networks to predict mechanisms of action, as demonstrated in studies of gastric cancer and COVID-19. Bioinformatics analyses of transcriptomic datasets identify differentially expressed genes and hub genes related to caspase activation.
RNA-seq and Transcriptomic Profiling
RNA sequencing allows global assessment of gene expression changes upon modulation of caspase activators. This method is useful for identifying downstream effectors and feedback loops.
Apoptosis Assays
Caspase activity assays, Annexin V staining, and TUNEL staining measure apoptotic cell death and caspase activation. These functional assays validate findings from computational predictions.
CRISPR-Based Functional Genomics
CRISPR knockout and library screening enable systematic interrogation of genes involved in caspase activation. Point mutations and knock-ins can dissect specific domains or residues required for activator function.
How CRISPR Can Be Used to Study GO:0008656 cysteine-type endopeptidase activator activity involved in apoptotic process
Knockout
CRISPR knockout of candidate caspase activator genes can determine whether they are required for apoptosis in a given cell model. For example, knocking out CASP8 or CASP9 abolishes specific apoptotic pathways.
Point Mutation
Introducing point mutations in caspase activator genes can dissect the functional domains responsible for binding and activating caspases. This approach helps distinguish between scaffolding and catalytic functions.
Knock-in
Knock-in of tagged versions of caspase activators (e.g., GFP or HA) allows visualization and immunoprecipitation of the protein in live cells. This is useful for studying localization and interactions.
Overexpression
Overexpression of a caspase activator can sensitize cells to apoptosis and reveal downstream effects. It is often used to confirm gain-of-function phenotypes.
How EDITGENE Supports cysteine-type endopeptidase activator activity involved in apoptotic process Research
Researchers studying cysteine-type endopeptidase activator activity involved in apoptotic process-related genes often need to determine whether a candidate gene is causally involved in caspase activation and cell death. EDITGENE provides a comprehensive suite of CRISPR services to enable such functional studies, from single-gene knockout to genome-wide library screening.
Contact EDITGENE today to design your custom CRISPR model for cysteine-type endopeptidase activator activity involved in apoptotic process research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| NGF Knockout HEK293 Cell Line | EDJ-KQ715 | Human | 4803 | Details Get a Quote |
| NOD1 Knockout HEK293 Cell Line | EDJ-KQ1045 | Human | 10392 | Details Get a Quote |
| BCL2L13 Knockout HEK293 Cell Line | EDJ-KQ1431 | Human | 23786 | Details Get a Quote |
| CASP1 Knockout HEK293 Cell Line | EDJ-KQ1456 | Human | 834 | Details Get a Quote |
| CASP8 Knockout HEK293 Cell Line | EDJ-KQ1474 | Human | 841 | Details Get a Quote |
| ATP2A3 Knockout HEK293 Cell Line | EDJ-KQ1563 | Human | 489 | Details Get a Quote |
| CTSH Knockout HEK293 Cell Line | EDJ-KQ2158 | Human | 1512 | Details Get a Quote |
| APAF1 Knockout HEK293 Cell Line | EDJ-KQ3019 | Human | 317 | Details Get a Quote |
| BEX3 Knockout HEK293 Cell Line | EDJ-KQ3055 | Human | 27018 | Details Get a Quote |
| NKX3-1 Knockout HEK293 Cell Line | EDJ-KQ5352 | Human | 4824 | Details Get a Quote |
| NLRP1 Knockout HEK293 Cell Line | EDJ-KQ7700 | Human | 22861 | Details Get a Quote |
| CASP8AP2 Knockout HEK293 Cell Line | EDJ-KQ12733 | Human | 9994 | Details Get a Quote |
| NOD1 Knockout A-549 Cell Line | EDJ-KQ20152 | Human | 10392 | Details Get a Quote |
| NOD1 Knockout HCT 116 Cell Line | EDJ-KQ20153 | Human | 10392 | Details Get a Quote |
| NOD1 Knockout HeLa Cell Line | EDJ-KQ20154 | Human | 10392 | Details Get a Quote |
- 1
- 2
- Next Page »
Frequently Asked Questions About cysteine-type endopeptidase activator activity involved in apoptotic process
What is GO:0008656?
GO:0008656 is the Gene Ontology molecular function term for cysteine-type endopeptidase activator activity involved in apoptotic process, which means binding to and increasing the rate of caspase proteolysis during apoptosis.
What genes are involved in cysteine-type endopeptidase activator activity involved in apoptotic process?
Key genes include CASP8, CASP9, APAF1, CYCS, TNFRSF10B, and BIRC family members, as identified in various studies.
What is caspase activator activity?
Caspase activator activity is a synonym for GO:0008656, describing proteins that enhance caspase protease activity during apoptosis.
How is cysteine-type endopeptidase activator activity involved in apoptotic process regulated?
It is regulated by inhibitor of apoptosis proteins (IAPs), pro-apoptotic BCL2 family members, and transcriptional factors such as TP53.
Which diseases are associated with dysregulated caspase activation?
Cancer, steroid-induced osteonecrosis of the femoral head, and neurodegenerative conditions have been linked to altered caspase activation.
What methods are used to study GO:0008656?
Network pharmacology, RNA-seq, bioinformatics, caspase activity assays, and CRISPR knockout models are commonly used.
Can CRISPR be used to study caspase activators?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are powerful tools to dissect caspase activator function.
What is the role of CASP8 in apoptosis?
CASP8 is an initiator caspase activated by death receptors, and its activation is promoted by activator proteins.
How does APAF1 contribute to caspase activation?
APAF1 forms the apoptosome with cytochrome c and activates CASP9, a key step in intrinsic apoptosis.
What services does EDITGENE offer for apoptosis research?
EDITGENE provides CRISPR knockout, point mutation, knock-in, overexpression, library screening, and bioinformatics services for apoptosis-related genes.
Conclusion
GO:0008656, cysteine-type endopeptidase activator activity involved in apoptotic process, is a critical molecular function that governs caspase activation and cell death. Its dysregulation is implicated in cancer, osteonecrosis, and other diseases, making it a valuable target for research. By leveraging CRISPR models and bioinformatics, researchers can uncover new insights into apoptosis regulation and identify therapeutic opportunities.
References
- 1. Tan XY et al.. 2023. [Mechanism of Astragali Radix-Curcumae Rhizoma in treating gastric cancer based on network pharmacology and experimental verification].. Zhongguo Zhong Yao Za Zhi 48(18):5056-5067 PMID: 37802848
- 2. Xiong H et al.. 2020. FKBP-related ncRNA-mRNA axis in breast cancer.. Genomics 112(6):4595-4607 PMID: 32814092
- 3. Chai JL et al.. 2023. Pyroptosis -related potential diagnostic biomarkers in steroid-induced osteonecrosis of the femoral head.. BMC Musculoskelet Disord 24(1):609 PMID: 37491198
- 4. Zhao XM et al.. 2021. Bioinformatics analysis of key biomarkers for retinoblastoma.. J Int Med Res 49(6):3000605211022210 PMID: 34187205
- 5. Guan S et al.. 2022. Bioinformatic identification of differentially expressed genes regulated by DNA-methylation in glioblastoma.. Eur J Neurosci 55(5):1278-1290 PMID: 34963193
- 6. Zhang H et al.. 2021. Screening and identification of key genes in imatinib-resistant chronic myelogenous leukemia cells: a bioinformatics study.. Hematology 26(1):408-414 PMID: 34053416
- 7. Yu B et al.. 2021. Network pharmacology study on the mechanism of the Chinese medicine Radix Isatidis (Banlangen) for COVID-19.. Medicine (Baltimore) 100(32):e26881 PMID: 34397905
- 8. Zhao C et al.. 2023. The effect of acute toxicity from tributyltin on Liza haematocheila liver: Energy metabolic disturbance, oxidative stress, and apoptosis.. Aquat Toxicol 258:106506 PMID: 36989927
